Answer
Zidovudine may compete with trifluridine in Trifluridine/Tipiracil Servier for activation by thymidine kinases, potentially reducing zidovudine efficacy, so monitor antiviral efficacy and consider an alternative antiviral that is not a human thymidine kinase substrate.
Sources for this answer
- Trifluridine/Tipiracil ServierServier Laboratories Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 12Document updated
Sources checked